Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Ultrafast Method Determines Antibiotic Resistance

By LabMedica International staff writers
Posted on 24 Aug 2017
Print article
Image: Klebsiella pneumoniae growing in the microfluidic chip imaged in phase contrast. The bacteria are 3 µm long and divide every 30 minutes (Photo courtesy of Özden Baltekina et al).
Image: Klebsiella pneumoniae growing in the microfluidic chip imaged in phase contrast. The bacteria are 3 µm long and divide every 30 minutes (Photo courtesy of Özden Baltekina et al).
Antibiotic resistance is a growing medical problem that threatens human health globally. One important contributory factor in the development of resistance is the incorrect use of antibiotics for treatment.

Reliable methods to quickly and easily identify bacterial resistance and provide the proper treatment from the start have not been possible because existing antibiotic resistance tests take too long. An antibiotic resistance test has been developed that is fast enough to enable a patient to take the right antibiotic home from the health center straight after the first appointment.

Scientists at Uppsala University (Sweden) developed a point-of-care susceptibility test for urinary tract infection, a disease that 100 million women suffer from annually and that exhibits widespread antibiotic resistance. They captured bacterial cells directly from samples with low bacterial counts (104 colony forming units [cfu]/mL) using a custom-designed microfluidic chip and monitor their individual growth rates using microscopy. By averaging the growth rate response to an antibiotic over many individual cells, they can reduce the detection time to the biological response time of the bacteria.

The microfluidic chip consists of a cover glass and a micro-molded silicon elastomer [polydimethylsiloxane (PDMS)] that are covalently bonded together. For micro-molding, they used the standard soft lithography techniques. Flow direction and rate during the study were maintained by pressure-driven flow. An OB1 Mk III electropneumatic controller regulated the air pressure applied to the closed fluidic reservoirs. The team used an Eclipse Ti-E inverted microscope for automated phase contrast microscopy.

The investigators were able to detect changes in growth rate in response to each of nine antibiotics that are used to treat urinary tract infections in minutes. In a test of 49 clinical uropathogenic Escherichia coli (UPEC) isolates, all were correctly classified as susceptible or resistant to ciprofloxacin in less than 10 minutes. The total time for antibiotic susceptibility testing, from loading of sample to diagnostic readout, was less than 30 minutes, which allows the development of a point-of-care test that can guide correct treatment of urinary tract infection.

Özden Baltekin, a PhD student, who performed most of the laboratory work and is the first author of the study said, “We've developed a new method that allows determination of bacterial resistance patterns in urinary tract infections in 10 to 30 minutes. By comparison, the resistance determination currently in use requires one to two days. The rapid test is based on a new plastic microfluidic chip where the bacteria are trapped and methods for analyzing bacterial growth at single-cell level.” The study was published on August 8, 2017, in the journal Proceedings of the National Academy of Sciences.

Related Links:
Uppsala University

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Vaginitis Test
Allplex Vaginitis Screening Assay
New
HIV Test
Anti-HIV (1/2) Rapid Test Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.